Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic–pituitary–adrenocortical axis responsiveness to stress

@article{Wulsin2010MifepristoneDD,
  title={Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic–pituitary–adrenocortical axis responsiveness to stress},
  author={Aynara C Wulsin and J. Herman and M. Solomon},
  journal={Psychoneuroendocrinology},
  year={2010},
  volume={35},
  pages={1100-1112}
}
  • Aynara C Wulsin, J. Herman, M. Solomon
  • Published 2010
  • Medicine, Psychology
  • Psychoneuroendocrinology
  • Glucocorticoid dyshomeostasis is observed in a proportion of depressed individuals. As a result, glucocorticoid receptor (GR) antagonists are currently being tested as potential anti-depressants. The current study was designed to test the efficacy of mifepristone, a GR antagonist, in mitigating behavioral, neuroendocrine and central nervous system (CNS) responses to an acute stressor. Adult male rats were treated for 5 days with mifepristone (10 mg/kg) and then exposed to the forced swim test… CONTINUE READING
    Resetting the Stress System with a Mifepristone Challenge
    • 11
    • Highly Influenced
    • Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 49 REFERENCES
    Stressor-selective role of the ventral subiculum in regulation of neuroendocrine stress responses.
    • 54
    • Open Access
    Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats
    • 418
    • Open Access